Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

CD4+ resident memory T cells dominate immunosurveillance and orchestrate local recall responses.

Beura LK, Fares-Frederickson NJ, Steinert EM, Scott MC, Thompson EA, Fraser KA, Schenkel JM, Vezys V, Masopust D.

J Exp Med. 2019 May 6;216(5):1214-1229. doi: 10.1084/jem.20181365. Epub 2019 Mar 28.

PMID:
30923043
2.

Use of a Blast Dominance-Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS).

Schenkel JM, Hergott CB, Dudley G, Drew M, Charest K, Dorfman DM.

Am J Clin Pathol. 2019 May 3;151(6):584-592. doi: 10.1093/ajcp/aqz004.

PMID:
30854558
3.

Plateletpheresis-associated lymphopenia in frequent platelet donors.

Gansner JM, Rahmani M, Jonsson AH, Fortin BM, Brimah I, Ellis M, Smeland-Wagman R, Li ZJ, Schenkel JM, Brenner MB, Yefidoff-Freedman R, Sloan SR, Berliner N, Issa NC, Baden LR, Longo DL, Wesemann DR, Neuberg D, Rao DA, Kaufman RM.

Blood. 2019 Feb 7;133(6):605-614. doi: 10.1182/blood-2018-09-873125. Epub 2018 Nov 14.

PMID:
30429159
4.

T Cells in Nonlymphoid Tissues Give Rise to Lymph-Node-Resident Memory T Cells.

Beura LK, Wijeyesinghe S, Thompson EA, Macchietto MG, Rosato PC, Pierson MJ, Schenkel JM, Mitchell JS, Vezys V, Fife BT, Shen S, Masopust D.

Immunity. 2018 Feb 20;48(2):327-338.e5. doi: 10.1016/j.immuni.2018.01.015.

5.

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.

Mehnert JM, Silk AW, Lee JH, Dudek L, Jeong BS, Li J, Schenkel JM, Sadimin E, Kane M, Lin H, Shih WJ, Zloza A, Chen S, Goydos JS.

Pigment Cell Melanoma Res. 2018 Jul;31(4):534-540. doi: 10.1111/pcmr.12694. Epub 2018 Apr 10.

6.

Intravital mucosal imaging of CD8+ resident memory T cells shows tissue-autonomous recall responses that amplify secondary memory.

Beura LK, Mitchell JS, Thompson EA, Schenkel JM, Mohammed J, Wijeyesinghe S, Fonseca R, Burbach BJ, Hickman HD, Vezys V, Fife BT, Masopust D.

Nat Immunol. 2018 Feb;19(2):173-182. doi: 10.1038/s41590-017-0029-3. Epub 2018 Jan 8.

7.

Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.

Jhawar SR, Thandoni A, Bommareddy PK, Hassan S, Kohlhapp FJ, Goyal S, Schenkel JM, Silk AW, Zloza A.

Front Oncol. 2017 Sep 11;7:202. doi: 10.3389/fonc.2017.00202. eCollection 2017. Review.

8.

T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.

Huang AC, Postow MA, Orlowski RJ, Mick R, Bengsch B, Manne S, Xu W, Harmon S, Giles JR, Wenz B, Adamow M, Kuk D, Panageas KS, Carrera C, Wong P, Quagliarello F, Wubbenhorst B, D'Andrea K, Pauken KE, Herati RS, Staupe RP, Schenkel JM, McGettigan S, Kothari S, George SM, Vonderheide RH, Amaravadi RK, Karakousis GC, Schuchter LM, Xu X, Nathanson KL, Wolchok JD, Gangadhar TC, Wherry EJ.

Nature. 2017 May 4;545(7652):60-65. doi: 10.1038/nature22079. Epub 2017 Apr 10.

9.

Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade.

Pauken KE, Sammons MA, Odorizzi PM, Manne S, Godec J, Khan O, Drake AM, Chen Z, Sen DR, Kurachi M, Barnitz RA, Bartman C, Bengsch B, Huang AC, Schenkel JM, Vahedi G, Haining WN, Berger SL, Wherry EJ.

Science. 2016 Dec 2;354(6316):1160-1165. Epub 2016 Oct 27.

10.

Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death.

Kohlhapp FJ, Huelsmann EJ, Lacek AT, Schenkel JM, Lusciks J, Broucek JR, Goldufsky JW, Hughes T, Zayas JP, Dolubizno H, Sowell RT, Kühner R, Burd S, Kubasiak JC, Nabatiyan A, Marshall S, Bommareddy PK, Li S, Newman JH, Monken CE, Shafikhani SH, Marzo AL, Guevara-Patino JA, Lasfar A, Thomas PG, Lattime EC, Kaufman HL, Zloza A.

Cell Rep. 2016 Oct 18;17(4):957-965. doi: 10.1016/j.celrep.2016.09.068.

11.

Heterologous Vaccination and Checkpoint Blockade Synergize To Induce Antileukemia Immunity.

Manlove LS, Schenkel JM, Manlove KR, Pauken KE, Williams RT, Vezys V, Farrar MA.

J Immunol. 2016 Jun 1;196(11):4793-804. doi: 10.4049/jimmunol.1600130. Epub 2016 Apr 25.

12.

Normalizing the environment recapitulates adult human immune traits in laboratory mice.

Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, Thompson EA, Fraser KA, Rosato PC, Filali-Mouhim A, Sekaly RP, Jenkins MK, Vezys V, Haining WN, Jameson SC, Masopust D.

Nature. 2016 Apr 28;532(7600):512-6. doi: 10.1038/nature17655. Epub 2016 Apr 20.

13.

IL-15-Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells.

Schenkel JM, Fraser KA, Casey KA, Beura LK, Pauken KE, Vezys V, Masopust D.

J Immunol. 2016 May 1;196(9):3920-6. doi: 10.4049/jimmunol.1502337. Epub 2016 Mar 21.

14.

Interleukin-2-Dependent Allergen-Specific Tissue-Resident Memory Cells Drive Asthma.

Hondowicz BD, An D, Schenkel JM, Kim KS, Steach HR, Krishnamurty AT, Keitany GJ, Garza EN, Fraser KA, Moon JJ, Altemeier WA, Masopust D, Pepper M.

Immunity. 2016 Jan 19;44(1):155-166. doi: 10.1016/j.immuni.2015.11.004. Epub 2015 Dec 29.

15.

NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade.

Kohlhapp FJ, Broucek JR, Hughes T, Huelsmann EJ, Lusciks J, Zayas JP, Dolubizno H, Fleetwood VA, Grin A, Hill GE, Poshepny JL, Nabatiyan A, Ruby CE, Snook JD, Rudra JS, Schenkel JM, Masopust D, Zloza A, Kaufman HL.

J Immunother Cancer. 2015 May 19;3:18. doi: 10.1186/s40425-015-0063-3. eCollection 2015.

16.

Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance.

Steinert EM, Schenkel JM, Fraser KA, Beura LK, Manlove LS, Igyártó BZ, Southern PJ, Masopust D.

Cell. 2015 May 7;161(4):737-49. doi: 10.1016/j.cell.2015.03.031.

17.

Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.

Pauken KE, Nelson CE, Martinov T, Spanier JA, Heffernan JR, Sahli NL, Quarnstrom CF, Osum KC, Schenkel JM, Jenkins MK, Blazar BR, Vezys V, Fife BT.

J Immunol. 2015 Apr 15;194(8):3551-3555. doi: 10.4049/jimmunol.1402262. Epub 2015 Mar 13.

18.

Tissue-resident memory T cells.

Schenkel JM, Masopust D.

Immunity. 2014 Dec 18;41(6):886-97. doi: 10.1016/j.immuni.2014.12.007. Epub 2014 Dec 6. Review.

19.

Lymphocytic choriomeningitis virus persistence promotes effector-like memory differentiation and enhances mucosal T cell distribution.

Beura LK, Anderson KG, Schenkel JM, Locquiao JJ, Fraser KA, Vezys V, Pepper M, Masopust D.

J Leukoc Biol. 2015 Feb;97(2):217-25. doi: 10.1189/jlb.1HI0314-154R. Epub 2014 Nov 13.

20.

T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses.

Schenkel JM, Fraser KA, Beura LK, Pauken KE, Vezys V, Masopust D.

Science. 2014 Oct 3;346(6205):98-101. doi: 10.1126/science.1254536. Epub 2014 Aug 28.

21.

High-dose IL-2 induces rapid albumin uptake by endothelial cells through Src-dependent caveolae-mediated endocytosis.

Zloza A, Kim DW, Broucek J, Schenkel JM, Kaufman HL.

J Interferon Cytokine Res. 2014 Nov;34(11):915-9. doi: 10.1089/jir.2013.0155. Epub 2014 Jun 25.

22.

Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells.

Kim DW, Zloza A, Broucek J, Schenkel JM, Ruby C, Samaha G, Kaufman HL.

J Transl Med. 2014 May 6;12:113. doi: 10.1186/1479-5876-12-113.

23.

Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells.

Mahmud SA, Manlove LS, Schmitz HM, Xing Y, Wang Y, Owen DL, Schenkel JM, Boomer JS, Green JM, Yagita H, Chi H, Hogquist KA, Farrar MA.

Nat Immunol. 2014 May;15(5):473-81. doi: 10.1038/ni.2849. Epub 2014 Mar 16.

24.

Cutting edge: resident memory CD8 T cells occupy frontline niches in secondary lymphoid organs.

Schenkel JM, Fraser KA, Masopust D.

J Immunol. 2014 Apr 1;192(7):2961-4. doi: 10.4049/jimmunol.1400003. Epub 2014 Mar 5.

25.

Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells.

Sakai S, Kauffman KD, Schenkel JM, McBerry CC, Mayer-Barber KD, Masopust D, Barber DL.

J Immunol. 2014 Apr 1;192(7):2965-9. doi: 10.4049/jimmunol.1400019. Epub 2014 Mar 3.

26.

Identification of a resident T-cell memory core transcriptional signature.

Schenkel JM, Masopust D.

Immunol Cell Biol. 2014 Jan;92(1):8-9. doi: 10.1038/icb.2013.67. Epub 2013 Oct 29. No abstract available.

PMID:
24165982
27.

Preexisting high frequencies of memory CD8+ T cells favor rapid memory differentiation and preservation of proliferative potential upon boosting.

Fraser KA, Schenkel JM, Jameson SC, Vezys V, Masopust D.

Immunity. 2013 Jul 25;39(1):171-83. doi: 10.1016/j.immuni.2013.07.003.

28.

The integration of T cell migration, differentiation and function.

Masopust D, Schenkel JM.

Nat Rev Immunol. 2013 May;13(5):309-20. doi: 10.1038/nri3442. Epub 2013 Apr 19. Review.

PMID:
23598650
29.

Sensing and alarm function of resident memory CD8⁺ T cells.

Schenkel JM, Fraser KA, Vezys V, Masopust D.

Nat Immunol. 2013 May;14(5):509-13. doi: 10.1038/ni.2568. Epub 2013 Mar 31. Erratum in: Nat Immunol. 2013 Aug;14(8):876.

30.

Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues.

Casey KA, Fraser KA, Schenkel JM, Moran A, Abt MC, Beura LK, Lucas PJ, Artis D, Wherry EJ, Hogquist K, Vezys V, Masopust D.

J Immunol. 2012 May 15;188(10):4866-75. doi: 10.4049/jimmunol.1200402. Epub 2012 Apr 13.

31.

NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.

Zloza A, Kohlhapp FJ, Lyons GE, Schenkel JM, Moore TV, Lacek AT, O'Sullivan JA, Varanasi V, Williams JW, Jagoda MC, Bellavance EC, Marzo AL, Thomas PG, Zafirova B, Polić B, Al-Harthi L, Sperling AI, Guevara-Patiño JA.

Nat Med. 2012 Feb 26;18(3):422-8. doi: 10.1038/nm.2683.

32.

IL-2 complex treatment can protect naive mice from bacterial and viral infection.

Hamilton SE, Schenkel JM, Akue AD, Jameson SC.

J Immunol. 2010 Dec 1;185(11):6584-90. doi: 10.4049/jimmunol.1001215. Epub 2010 Oct 29.

33.

Beta-catenin signaling mediates CD4 expression on mature CD8+ T cells.

Schenkel JM, Zloza A, Li W, Narasipura SD, Al-Harthi L.

J Immunol. 2010 Aug 15;185(4):2013-9. doi: 10.4049/jimmunol.0902572. Epub 2010 Jul 14.

34.

Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface.

Zloza A, Schenkel JM, Tenorio AR, Martinson JA, Jeziorczak PM, Al-Harthi L.

Blood. 2009 Oct 29;114(18):3841-53. doi: 10.1182/blood-2009-02-202481. Epub 2009 Aug 21.

Supplemental Content

Loading ...
Support Center